Правове регулювання компенсації здоровим добровольцям участі у клінічних випробуваннях
Анотація
У статті висвітлено існуючі прогалини, що стосуються правової невизначеності статусу суб’єктів клінічних випробувань. Розглянуто питання необхідності нормативного закріплення у вітчизняному законодавстві способів та видів компенсації суб’єктам клінічних випробувань – здоровим добровольцям. Проаналізовано основні підходи до визначення компенсації та/або винагороди здоровим добровольцям за участь у клінічному випробуванні, що існують у вітчизняній та зарубіжній практиці, обґрунтовано пропозицію автора щодо включення відповідної норми до українського законодавства.
Посилання
Pro likarski zasoby: Zakon Ukrainy vid 04.04.1996 No 123/96-VR [On Medicinal Products: Law of Ukraine dated 04.04.1996 No. 123/96-BP]. Vidom. Verkhov. Rady Ukrainy. – Proceedings of Verkhovna Rada of Ukraine. 1996. – No22. – St.86 [in Ukrainian]. 2. Pro zatverdzhennia Poriadku provedennia klinichnykh vyprobuvan likarskykh zasobiv ta ekspertyzy materialiv klinichnykh vyprobuvan i Typovoho polozhennia pro komisii z pytan etyky. Nakaz MOZ Ukrainy vid 23.09.2009 No 690 [On Approval of the Procedure for Conducting Clinical Trials of Medicinal Products and Examination of Materials for Clinical Trials and the Model Regulations on the Ethics Commission: Order of the Ministry of Health of Ukraine dated September 23, 2009 No. 690]. Ofitsiinyi visnyk Ukrainy – Official Herald of Ukraine. 2009. – No 87. – St. 2948. [in Ukrainian]. 3. Likarski zasoby. Nalezhna klinichna praktyka: Nastanova 42-7.0:2008 [Medicines. Good clinical practice: Manual 42-7.0: 2008] Ministerstvo okhorony zdorovia Ukrainy. Ofits. vyd. – Ministry of Health of Ukraine. Official edition. K.: Vyd-vo TOV «MORION», 2009. – 67 s. [in Ukrainian]. 4. Likarski zasoby. Doslidzhennia bioekvivalentnosti : Nastanova 42-7.1:2016 [Medicines. Investigation of bioequivalence: Manual 42-7.1: 2016] Ministerstvo okhorony zdorovia Ukrainy – Ministry of Health of Ukraine. Official edition Ofits. vyd. – K.: Vyd-vo TOV «MORION», 2016. – 72 s. [in Ukrainian]. 5. Dobrova V. Ye., Zupanets I. A., Starchenko M. H., Kotenko O. M. (2011) Obgruntuvannia ta rozrobka metodyky rozrakhunku kompensatsii uchasti zdorovykh dobrovoltsiv u klinichnykh vyprobuvanniakh z urakhuvanniam suchasnykh vymoh [Substantiation and development of a method for calculating compensation for the participation of healthy volunteers in clinical trials, taking into account modern requirements.]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. –Management, Economics and Quality Assurance in Pharmacy. Vol. 5(19). 9–14. [in Ukrainian]. 6. Harry JD. Research on healthy volunteers--a report of the Royal College of Physicians. British Journal of Clinical Pharmacology. 1987;23(4). 379–381 [in English]. 7. Clinical trial compensation guidelines. Association of British Pharmaceuticals Industries. London, 12 November 2014. abpi.org.uk. Retrieved from http://www.abpi.org.uk/our-work/library/guidelines/Documents/compensation_ guidelines_2014.pdf [in English]. 8. Guidelines for phase 1 clinical trials. Association of British Pharmaceuticals Industries. London, 14 August 2012. abpi.org.uk. Retrieved from http://www.abpi.org.uk/our-work/library/guidelines/Documents/guidelines_phase1_ clinical_trials.pdf [in English]. 9. European medicines agency. Pharmacokinetic studies in man. (Notice to Applicant, Vol. 3C, 3CC3A, 1987). ema. europa.eu. Retrieved from http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/ WC500003127.pdf [in English]. 10. Ob organizatsii otdeleniy klinicheskikh ispytaniy lekarstvennykh preparatov na zdorovykh dobrovoltsakh [On the organization of clinical trials of drugs in healthy volunteers] Prikaz Ministerstva zdravookhraneniya RSFSR ot 25.08.1992 No 235 – Order of the Ministry of Health of the RSFSR of August 25, 1992 No. 235 [in Russian]. 11. Printsipi ukladennya dogovorіv pri provedennі klіnіchnikh viprobuvan lіkarskikh zasobіv u kontekstі suchasnogo zakonodavstva Ukraїni (metodichnі rekomendatsії) [Principles of conclusion of contracts during conducting of clinical trials of medicinal products in the context of modern legislation of Ukraine (methodical recommendations)]. apteka. ua. Retrieved from http://www.apteka.ua/article/235396 [in Russian]. 12. Pasqualetti G, Gori G, Blandizzi C, Del Tacca M. Healthy volunteers and early phases of clinical experimentation. Eur J Clin Pharmacol. 2010;66:647–653 [in English]. 13. Giovanni Gori, Giuseppe Pasqualetti, Catia Castiglioni, Corrado Blandizzi and Mario Del Tacca (2011). Drug Experimentation in Healthy Volunteers, Drug Development A Case Study Based Insight into Modern Strategies, Dr. Chris Rundfeldt (Ed.), InTech, DOI: 10.5772/27919. Retrieved from https://www.intechopen.com/books/drugdevelopment-a-case-study-based-insight-into-modern-strategies/drug-experimentation-in-healthy-volunteers [in English]. 14. Iltis, Ana S. Payments to Normal Healthy Volunteers in Phase 1 Trials: Avoiding Undue Influence While Distributing Fairly the Burdens of Research Participation. The Journal of Medicine and Philosophy 34.1 (2009): 68–90. PMC. Web. 28 Sept. 2017 [in English]. 15. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance []. Official Journal of the European Union – 27.5.2014. – L 158. – Р. 1–76 [in English]. 16. Directive 2001/20/EC OF the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Retrieved from http://ec.europa.eu/ health/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf [in English]. 17. Dobrova V. Ye. Starchenko M. H., Zupanets I. A., Kotenko O. M. (2011). Analiz faktoriv dyskomfortu z urakhuvanniam vymoh do nalezhnoho planuvannia klinichnykh vyprobuvan za uchastiu zdorovykh dobrovoltsiv [Analysis of discomfort factors, taking into account the requirements for proper planning of clinical trials with the participation of healthy volunteers.] Zaporozhskyi medytsynskyi zhurnal – Zaporozhye Medical Journal. 2011. 5. 16–21 [in Ukrainian]. 18. Dobrova V. Ye. (2013). Metodychni zasady otsinky finansovoi kompensatsii uchasti dobrovoltsiv u klinichnykh vyprobuvanniakh [Methodological principles for assessing the financial compensation of volunteers’ participation in clinical trials]. Zaporozhskyi medytsynskyi zhurnal – Zaporozhye Medical Journal. 5. 112–115 [in Ukrainian]. 19. Zupanets, I. A. Starchenko M. H., Dobrova V. Ye. (2010). Metodolohichni ta orhanizatsiini aspekty provedennia klinichnykh vyprobuvan za uchastiu zdorovykh dobrovoltsiv [Methodological and organizational aspects of conducting clinical trials involving healthy volunteers]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii – Management, Economics and Quality Assurance in Pharmacy. 4. 4–10 [in Ukrainian].
